Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback